首页> 外文期刊>Balkan journal of medical genetics: BJMG >FAMILIAL NON-AUTOIMMUNE HYPERTHYROIDISM IN FAMILY MEMBERS ACROSS FOUR GENERATIONS DUE TO A NOVEL DISEASE-CAUSING VARIANT IN THE THYROTROPIN RECEPTOR GENE
【24h】

FAMILIAL NON-AUTOIMMUNE HYPERTHYROIDISM IN FAMILY MEMBERS ACROSS FOUR GENERATIONS DUE TO A NOVEL DISEASE-CAUSING VARIANT IN THE THYROTROPIN RECEPTOR GENE

机译:由于甲状腺素受体基因的一种新型疾病导致变体,在四代家庭非自身免疫甲状腺功能亢进症

获取原文
获取原文并翻译 | 示例
           

摘要

Activating disease-causing variants in the thyrotropin-receptor (TSHR) gene are associated with familial or sporadic congenital non-autoimmune hyperthyroidism. Familial non-autoimmune hyperthyroidism (FNAH) is a rare form of hyperthyroidism with 41 families reported so far in the TSHR gene mutation database. We present clinical and genetic features of 11 patients with FNAH across four generations of a Slovenian family. They all developed clinical features of hyperthyroidism but did not show characteristics of autoimmune hyperthyroidism. Members of the initially diagnosed generation were diagnosed as hyperthyrotic after they developed cardiac complications (rhythm disorders, thromboembolic events, cardiac insufficiency), while patients in the younger generations were diagnosed earlier, and consequently, early cardiovascular complications were less frequent. All patients had a novel heterozygous TSHR variant NP_000360.2: p.Met453Val (NM_000369.2: c.1357A>G) predicted to be pathogenic. Therefore, besides expending the mutational spectrum of the activating TSHR variants in FNAH, our experience with this multi-generation family confirms the need for early diagnosis and appropriate treatment of FNAH.
机译:促甲状腺素受体(TSHR)基因中激活致病变异体与家族性或散发性先天性非自身免疫性甲亢相关。家族性非自身免疫性甲状腺机能亢进症(FNAH)是一种罕见的甲状腺机能亢进症,迄今已有41个家族在TSHR基因突变数据库中报告。我们介绍了斯洛文尼亚家族四代11例FNAH患者的临床和遗传学特征。他们都有甲状腺功能亢进的临床特征,但没有表现出自身免疫性甲状腺功能亢进的特征。最初诊断的一代患者在出现心脏并发症(心律失常、血栓栓塞事件、心功能不全)后被诊断为甲状腺功能亢进,而年轻一代患者被诊断得更早,因此早期心血管并发症的发生率较低。所有患者都有一种新的杂合TSHR变体NP_000360.2:p.Met453Val(NM_000369.2:c.1357A>G)被预测为致病性。因此,除了扩大FNAH中激活TSHR变异体的突变谱外,我们对这一多代家族的经验证实了对FNAH进行早期诊断和适当治疗的必要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号